BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30255255)

  • 1. Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI.
    Iyama A; Nakaura T; Iyama Y; Kidoh M; Nagayama Y; Oda S; Utsunomiya D; Namimoto T; Morita K; Yuba K; Yamashita Y
    Eur Radiol; 2019 Apr; 29(4):2009-2016. PubMed ID: 30255255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radial volumetric imaging breath-hold examination (VIBE) with k-space weighted image contrast (KWIC) for dynamic gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI of the liver: advantages over Cartesian VIBE in the arterial phase.
    Fujinaga Y; Ohya A; Tokoro H; Yamada A; Ueda K; Ueda H; Kitou Y; Adachi Y; Shiobara A; Tamaru N; Nickel MD; Maruyama K; Kadoya M
    Eur Radiol; 2014 Jun; 24(6):1290-9. PubMed ID: 24633374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA.
    Zech CJ; Vos B; Nordell A; Urich M; Blomqvist L; Breuer J; Reiser MF; Weinmann HJ
    Invest Radiol; 2009 Jun; 44(6):305-10. PubMed ID: 19462484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate.
    Schmid-Tannwald C; Herrmann K; Oto A; Panteleon A; Reiser M; Zech C
    Acta Radiol; 2012 Nov; 53(9):961-5. PubMed ID: 23024179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison.
    Cannella R; Brancatelli G; Rangaswamy B; Minervini MI; Borhani AA; Furlan A
    Eur J Radiol; 2019 Oct; 119():108633. PubMed ID: 31437747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA.
    Li H; Xiao Y; Wang S; Li Y; Zhong X; Situ W; Xiao E; Zhang Z
    Clin Radiol; 2017 Sep; 72(9):800.e1-800.e6. PubMed ID: 28476245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
    Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
    World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.
    Fujinaga Y; Ohya A; Matsushita T; Kurozumi M; Ueda K; Kitou Y; Ueda H; Kadoya M
    Jpn J Radiol; 2011 Dec; 29(10):695-700. PubMed ID: 22009420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver.
    Tamada T; Ito K; Yoshida K; Kanki A; Higaki A; Tanimoto D; Higashi H
    Eur J Radiol; 2011 Dec; 80(3):e284-8. PubMed ID: 21296514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
    Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
    Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Timing of Hepatic Arterial Phase and Image Quality Using Test-Bolus and Bolus-Tracking Techniques in Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Hepatic Dynamic Magnetic Resonance Imaging.
    Iyama Y; Nakaura T; Yokoyama K; Kidoh M; Utsunomiya D; Oda S; Namimoto T; Yamashita Y
    J Comput Assist Tomogr; 2017; 41(4):638-643. PubMed ID: 28240635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of self-gated isotropic radial late-phase MR imaging of the liver.
    Weiss J; Taron J; Othman AE; Grimm R; Kuendel M; Martirosian P; Ruff C; Schraml C; Nikolaou K; Notohamiprodjo M
    Eur Radiol; 2017 Mar; 27(3):985-994. PubMed ID: 27271925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?
    Haradome H; Grazioli L; Tsunoo M; Tinti R; Frittoli B; Gambarini S; Morone M; Motosugi U; Colagrande S
    J Magn Reson Imaging; 2010 Aug; 32(2):334-40. PubMed ID: 20677259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid-enhanced liver MRI.
    Poetter-Lang S; Dovjak GO; Messner A; Ambros R; Polanec SH; Baltzer PAT; Kristic A; Herold A; Hodge JC; Weber M; Bastati N; Ba-Ssalamah A
    Eur Radiol; 2023 Jan; 33(1):523-534. PubMed ID: 35895119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
    Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
    Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.